INTCO Medical is a medical products manufacturing company.
INTCO Medical, established in 2009 and headquartered in Shandong, is a high-tech manufacturing company committing to R&D, production, and marketing of disposable medical products and durable medical equipment. Founded by Liu Fangyi, it was listed on Shenzhen Stock Exchange in July 2017. The company's major shareholders are Liu Fangyi, Hong Kong Securities Clearing, and Industrial And Commercial Bank Of China Limited. Its primary competitors include Winner Medicals, Transtek, Blue Sail Plastic & Rubber.
We-Linking Raised Over CNY 10 Mn in Angel Round
Intraoperative Neurophysiological Monitoring Equipment Developer NeuroFlag Closed An Angel Round
Surgerii Robotics: Single-Port Surgical Robots Poised to Transform Surgery
The worldwide surgical robotic market is expected to grow at a booming CAGR of 5.8% during 2022 to 2030, rising from USD 5.05 billion in 2022 to USD 21.41 billion in 2030. Of which, the single-port surgical robots that result in less pain, fewer scars, and quicker recovery, have tremendous up potential.
Mar 30, 2023 04:00 PM
The winning lot number of Meinong biology was released: 40000 in total
Yingke medical: at present, the production capacity of nitrile gloves of the company is about 9 times of the pre epidemic level
2022 China AI Health 30 Report
Bank of Changsha: approved to issue special financial bonds for small and micro enterprise loans of no more than 5 billion yuan
Mask protection unit rose in the afternoon
Yingke medical: it plans to invest 130 million yuan in Changzhou Yunchang
Mu Gaodi: elect Lu Huang, chairman of Huawei
HastenPharma Secures USD 315 Mn in Financing to Focus on M&A Business and R&D
Anhui-based biopharmaceutical company HastenPharma(海森生物) raised USD 315 million in funding on April 20, with the financing round aimed at focusing on future mergers and acquisitions and product innovation, according to EqualOcean.
Apr 23, 2023 12:20 PM
Artificial Cardiac Company CoretechMed Raises Nearly CNY 200 Mn in Series C+
In the past five years, China's ventricular assist technology (i.e., "artificial heart") has developed rapidly, and three domestic implantable ventricular assist devices (LVADs) have been approved and marketed by the State Drug Administration, and another one is in the marketing declaration stage. The number of LVAD implantations has increased yearly, with a total of 363 LVAD implantations performed in 70 hospitals, a rapid increase.
Apr 17, 2023 05:12 PM
Yingke medical: it is expected that the net profit in the third quarter will decrease by 55.13% - 63.28% year-on-year
Emma Technology: it plans to invest 2 billion yuan to build Emma southwest manufacturing base
Antiviral stocks rose in the afternoon
Global Leader in Radiosurgery Robots ZAP Sets Up China Headquarters in Suzhou
The China headquarters project of the ZAP-X photon surgery robot, led by ZAP, a global leader in the next-generation robotic surgical systems and a leading player in non-invasive brain surgery robots, has officially signed an agreement to settle in Suzhou.
Apr 13, 2023 04:06 PM
Clinical Microbiology Testing Company WillingMed Nets More than 100 Mn in Series B
WillingMed has independently developed and successfully reported and approved a series of automated testing instruments, software, testing reagents and other IVD products, and obtained intellectual property rights for more than 40 core technologies.
Apr 07, 2023 09:09 PM
The latest position of Qu Yang, fund manager of Qianhai open source: Hong Kong stocks redistributed, Tencent holdings and BYD holdings increased
Global supply of gloves may be blocked due to the outbreak in Malaysia, Yingke medical said it has received some transfer orders
The three major indexes opened lower collectively
Major shareholders and senior executives collectively reduce their holdings of Yingke medical, with a 17.2% drop in the opening price